Zhijie Wang

机构：Hubei University of Medicine, Second Military Medical University, Chinese Academy of Medical Sciences & Peking Union Medical College, Westlake University, National Cancer Center, National Clinical Research Center for Digestive Diseases, Changhai Hospital, Zhejiang Hospital, Second Affiliated Hospital of Nanjing Medical University, Hangzhou First People's Hospital, Molecular Oncology (United States), State Key Laboratory of Molecular Oncology, Nanjing Medical University, Nanjing University · ORCID：0000-0001-8015-5413

发表论文 90 篇 · 总被引 1742 次 · h-index 19

代表论文

• Neutrophil-derived PAD4 induces citrullination of CKMT1 exacerbates mucosal inflammation in inflammatory bowel disease (2024 · Cellular and Molecular Immunology · 被引 58)
• CKMT1 deficiency contributes to mitochondrial dysfunction and promotes intestinal epithelial cell apoptosis via reverse electron transfer-derived ROS in colitis (2025 · Cell Death and Disease · 被引 19)
• Cathepsin V is correlated with the prognosis and tumor microenvironment in liver cancer (2023 · Molecular Carcinogenesis · 被引 17)
• Toripalimab plus chemotherapy for first line treatment of advanced non-small cell lung cancer (CHOICE-01): final OS and biomarker exploration of a randomized, double-blind, phase 3 trial (2024 · Signal Transduction and Targeted Therapy · 被引 16)
• Mitochondrial damage-associated molecular patterns: New perspectives for mitochondria and inflammatory bowel diseases (2025 · Mucosal Immunology · 被引 15)
• Evaluation of a plasma cell-free DNA methylation test for colorectal cancer diagnosis: a multicenter clinical study (2024 · BMC Medicine · 被引 14)